NEUROTROPHIC FACTOR PROTEIN CONJUGATES AND RELATED EMBODIMENTS Application EP-3946413-A4 European Patent Office 11 Jan 2023
Engineered clostridium botulinum toxin adapted to deliver molecules into selected cells Grant US-11118170-B2 United States of America 14 Sep 2021
Engineered Clostridium botulinum toxin adapted to deliver molecules into selected cells Grant US-10633643-B2 United States of America 28 Apr 2020
ENGINEERED CLOSTRIDIUM BOTULINUM TOXIN ADAPTED TO DELIVER MOLECULES INTO SELECTED CELLS Application WO-2016187076-A1 World Intellectual Property Organisation (WIPO) 24 Nov 2016